What companies are BIB's competitors?

ProShares Ultra Nasdaq Biotechnology (BIB)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does BIB compare to its peers?

The peer comparison table on this page shows ProShares Ultra Nasdaq Biotechnology (BIB) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does BIB operate in?

ProShares Ultra Nasdaq Biotechnology (BIB) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

BIB

ProShares Ultra Nasdaq Biotechnology

NASDAQ·Asset Management · Financial Services

$109.87$0.09+0.08%

Market cap$88.99M·Sep 14 2:22 PM UTC

Frequently Asked Questions About BIB

What companies are BIB's competitors?: ProShares Ultra Nasdaq Biotechnology (BIB)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does BIB compare to its peers?: The peer comparison table on this page shows ProShares Ultra Nasdaq Biotechnology (BIB) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does BIB operate in?: ProShares Ultra Nasdaq Biotechnology (BIB) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

BIB

ProShares Ultra Nasdaq Biotechnology

NASDAQ·Asset Management · Financial Services

$109.87$0.09+0.08%

Market cap$88.99M·Sep 14 2:22 PM UTC

Peers


ITDC	iShares LifePath Target Date 2035 ETF	$36.61	$103.2M
GOP	Subversive Congressional Republicans Trading ETF	$44.10	$89.7M
BKSE	BNY Mellon US Small Cap Core Equity ETF	$43.20	$85.6M
NACP	Impact Shares NAACP Minority Empowerment ETF	$59.61	$77.8M
RSEE	Rareview Systematic Equity ETF	$38.22	$73.5M
TRND	Pacer Trendpilot Fund of Funds ETF	$36.97	$66.0M
CAMX	Cambiar Aggressive Value ETF	$34.37	$64.4M
DIVL	Madison Dividend Value ETF	$25.33	$60.2M
SNTH	MRP SynthEquity ETF	$29.74	$54.5M
URE	ProShares Ultra Real Estate	$65.81	$51.5M

Frequently Asked Questions About BIB

What companies are BIB's competitors?: ProShares Ultra Nasdaq Biotechnology (BIB)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does BIB compare to its peers?: The peer comparison table on this page shows ProShares Ultra Nasdaq Biotechnology (BIB) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does BIB operate in?: ProShares Ultra Nasdaq Biotechnology (BIB) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.